# Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-efficacy-of-routinely-administered-belimumab-on-proteinuria-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marlene Plüß,Björn Tampe,Noah Niebusch,Michael Zeisberg,Gerhard A. Müller,Peter Korsten |
| Citations | 21 |
| DOI | 10.3389/fmed.2020.00222 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fmed.2020.00222/pdf |
| OpenAlex ID | https://openalex.org/W3030096585 |
| PMID | 32537456 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Marlene Plüß](https://scholariq.org/researchers/marlene-plu/)

## Paper journal

- [Frontiers in Medicine](https://scholariq.org/journals/frontiers-in-medicine/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.